Why is this study important?
- Proof of concept of new technique for direct reduction in mitral valve annular area.
- Identified a potential new adjunctive therapy to current TEER procedures.
What question was this study supposed to answer?
- Previous attempts at annular reduction using the coronary sinus have been disappointing.
- This study demonstrated the technical feasibility of intramyocardial device delivery.
What did the study show?
- Procedural success in a small group (n=19) of HFpEF and HFrEF patients with persistent MR after TEER.
- The ability to evaluate the procedural success and potential complications and stop the procedure without complications.
- Improvement in both physiologic parameters and clinical functional status.
All authors: Steven R. Bailey, MD, MSCAI
Other Specialist Resources for Structural Heart Disease
Including recently published studies, coverage of late-breaking science, updates from clinical trials and registries, and complex case presentations.
Clinical Interest Article
SCAI Guidelines for the Management of Patent Foramen Ovale—Coverage of SCAI 2022 Scientific Sessions
Clinical Interest Article
ADAPT-TAVR Trial—Coverage of ACC.22
Routine Use of Edoxaban Post-TAVR in Patients Without an Indication for Anticoagulation Does Not Significantly Reduce Valve Thrombo...
Clinical Interest Article
SURTAVI at 5 Years—Coverage of ACC.22
Self-Expanding TAVR in Intermediate-Risk Patients Non-Inferior to SAVR at 5 Years